Meet Adrienne Flanagan, Professor of Musculo- Skeletal Pathology at University College London’s Cancer Institute. As a highly accomplished medical researcher, Dr. Flanagan works closely with patient groups and focuses on identifying the genetic…

Interesting article suggesting bone (and other) cancers contain a microenvironment conducive to distinctive bacterial populations https://medicalxpress.com/…/2020-05-cells-bacteria-cancer.h… Cancer cells are comfy havens for bacteria. That…

Mike Snyder, a CS Warrior from Albuquerque, New Mexico and author of his book entitled: No Treatment Options Left: Fighting and Surviving Inoperable Cancer, contributed the first of many commentaries to provide straightforward information to CS…

Please click the link below and register for the webinar on Progress on Research in Chondrosarcoma with Professor Adrienne Flanagan on June 26

 Did You Know? Chondrosarcoma is an extremely rare form of cancer that accounts for only about 20% of malignant bone tumors and is diagnosed in approximately 600 patients each year in the United States. Not only is Chondrosarcoma difficult to…

A cancer diagnosis is a life-changing experience that will inevitably have a tremendous effect on ones health. For the patient this includes not only physical health, but mental, emotional and spiritual health as well. We want the Chondrosarcoma…

Chondrosarcoma is a cancer composed of cells derived from transformed cells that produce cartilage. Chondrosarcoma is a member of a category of tumors of bone and soft tissue known as sarcomas. About 30% of skeletal system cancers are…

This will be the first of many posts to provide straightforward information to patients and their families about Chondrosarcoma. First, a monthly article will be submitted to provide answers to questions, information on clinical trials, research…